Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.420
+0.200 (4.74%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $237.72 million as of June 18, 2026. Its market cap has increased by 198.59% in one year.
Market Cap
237.72M
Enterprise Value
114.68M
1-Year Change
198.59%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $237.72M, a decrease of -56.04%. That is a compound annual growth rate of -15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 237.72M | 108.44% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 246.54M |
| Foghorn Therapeutics | 243.66M |
| Fate Therapeutics | 243.61M |
| Sol-Gel Technologies | 243.41M |
| Orchestra BioMed Holdings | 238.92M |
| AC Immune | 238.08M |
| Canton Strategic Holdings | 233.85M |
| Cybin | 233.67M |